XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify the non-inferiority of the combination therapy of
Capecitabine and Oxaliplatin compared with the combination therapy of Fluorouracil/Folinic
acid and Oxaliplatin in patients with advanced gastric cancer.